Lipocine Investor Room http://ir.lipocine.com/ Lipocine Announces LPCN 1144 Clinical Trial Results Selected for Late-Breaker Presentation at The Liver Meeting® 2018 http://ir.lipocine.com/2018-10-11-Lipocine-Announces-LPCN-1144-Clinical-Trial-Results-Selected-for-Late-Breaker-Presentation-at-The-Liver-Meeting-R-2018 Thu, 11 Oct 2018 08:00:00 -0400 http://ir.lipocine.com/2018-10-11-Lipocine-Announces-LPCN-1144-Clinical-Trial-Results-Selected-for-Late-Breaker-Presentation-at-The-Liver-Meeting-R-2018 Lipocine to Present at the Ladenburg Thalmann 2018 Healthcare Conference http://ir.lipocine.com/2018-09-25-Lipocine-to-Present-at-the-Ladenburg-Thalmann-2018-Healthcare-Conference Tue, 25 Sep 2018 08:00:00 -0400 http://ir.lipocine.com/2018-09-25-Lipocine-to-Present-at-the-Ladenburg-Thalmann-2018-Healthcare-Conference Lipocine Announces Financial and Operational Results for the Second Quarter and Six Months Ended June 30, 2018 http://ir.lipocine.com/2018-08-07-Lipocine-Announces-Financial-and-Operational-Results-for-the-Second-Quarter-and-Six-Months-Ended-June-30-2018 Tue, 07 Aug 2018 07:30:00 -0400 http://ir.lipocine.com/2018-08-07-Lipocine-Announces-Financial-and-Operational-Results-for-the-Second-Quarter-and-Six-Months-Ended-June-30-2018 Lipocine to Present at the Canaccord Genuity 38th Annual Growth Conference http://ir.lipocine.com/2018-08-02-Lipocine-to-Present-at-the-Canaccord-Genuity-38th-Annual-Growth-Conference Thu, 02 Aug 2018 08:00:00 -0400 http://ir.lipocine.com/2018-08-02-Lipocine-to-Present-at-the-Canaccord-Genuity-38th-Annual-Growth-Conference Lipocine Announces Dosing in Ambulatory Blood Pressure Study for TLANDO™ http://ir.lipocine.com/2018-06-07-Lipocine-Announces-Dosing-in-Ambulatory-Blood-Pressure-Study-for-TLANDO-TM Thu, 07 Jun 2018 08:00:00 -0400 http://ir.lipocine.com/2018-06-07-Lipocine-Announces-Dosing-in-Ambulatory-Blood-Pressure-Study-for-TLANDO-TM